gimli

FREDUN stock AI analysis

FREDUN Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

FREDUN PHARMACEUTICALS L is a small-cap stock in Healthcare. This Gimli page shows the latest available FREDUN price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive FREDUN stock page

Price

₹1,552.30

1W return

+14.54%

1M return

+7.86%

3M return

n/a

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+20.72%

ROCE

+23.96%

RSI

65.29

Turnover

₹70.00 cr

Why it can matter in screens

Momentum: FREDUN is below 50DMA, below 200DMA; RSI is 65.29.
Returns: 1D +1.34%, 1W +14.54%, 1M +7.86%, 3M n/a, 1Y n/a.
Trend levels: 52W high ₹1,665.00, 52W low ₹1,195.20, off high -6.77%.
Liquidity: latest turnover is ₹70.00 cr; volume vs 20D is +2.87%.
Valuation/profitability: PE n/a, PB n/a, ROE +20.72%, ROCE +23.96%.
Growth: 3Y sales CAGR +32.16%, 3Y profit CAGR +44.49%.

Quick Answers

What is the latest FREDUN stock price?

The latest stored price for FREDUN is Rs 1,552.30 as of 2026-10-09.

Is FREDUN above its 50DMA and 200DMA?

FREDUN is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are FREDUN PE, ROE and ROCE?

FREDUN has PE n/a, ROE +20.72%, and ROCE +23.96% in Gimli's latest available snapshot.

How has FREDUN performed recently?

FREDUN has returned +7.86% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	227.76 cr	32.74 cr	13.13 cr	n/a
2026-03-31	210.41 cr	28.88 cr	10.78 cr	n/a
2025-12-31	159.93 cr	26.34 cr	10.48 cr	n/a
2025-09-30	143.59 cr	22.33 cr	9.43 cr	n/a
2025-06-30	119.40 cr	16.99 cr	6.77 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	633.33 cr	92.73 cr	32.62 cr	0.00
2025-03-31	451.71 cr	52.96 cr	19.74 cr	0.00
2024-03-31	346.58 cr	37.77 cr	15.62 cr	11.22
2023-03-31	274.34 cr	27.88 cr	10.81 cr	8.04
2022-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	642.08 cr	64.93 cr	242.27 cr	281.62 cr
2025-03-31	487.41 cr	0.64 cr	168.38 cr	141.38 cr
2024-03-31	307.60 cr	1.07 cr	105.51 cr	121.47 cr
2023-03-31	257.28 cr	2.95 cr	86.55 cr	96.38 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	11.90 cr	-61.69 cr	n/a
2025-03-31	-16.60 cr	-22.70 cr	n/a
2024-03-31	-0.44 cr	-8.08 cr	n/a
2023-03-31	-14.41 cr	-23.90 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	422,282.96 cr	34.857273	+15.50%	+6.12%
DIVISLAB	DIVI S LABORATORIES LTD	247,947.67 cr	85.088426	+18.37%	+52.32%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,610.64 cr	72.265309	+17.33%	+31.16%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	115,423.17 cr	58.937484	+21.03%	+4.32%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	112,446.65 cr	25.058308	+16.04%	+12.37%
LAURUSLABS	LAURUS LABS LIMITED	109,947.20 cr	100.670416	+21.77%	+135.42%
CIPLA	CIPLA LTD	105,094.85 cr	31.162389	+10.25%	-14.02%
DRREDDY	DR. REDDY S LABORATORIES	99,661.60 cr	30.096514	+9.23%	-3.94%

Try these prompts

Analyze FREDUN PHARMACEUTICALS L with valuation, momentum and industry peers
Compare FREDUN with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-10-09. Not investment advice.